A skull ultrasound implant that opens the barrier at every cycle

Implantable ultrasound emitters have been used in recurrent glioblastoma trials with carboplatin and with albumin-bound paclitaxel, showing repeated safe barrier opening and increased brain drug concentrations. The remaining questions are whether the added exposure translates into survival, and which drug benefits most from repeated opening.